SciELO - Scientific Electronic Library Online

 
vol.77 número3Clinical and cerebrospinal fluid findings contribute to the early differentiation between infectious and noninfectious encephalitisNeurografía por resonancia magnética para la identificación de la neuralgia del nervio pudendo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Medicina (Buenos Aires)

versión impresa ISSN 0025-7680versión On-line ISSN 1669-9106

Resumen

GONZALEZ-CALLE, Verónica  y  FONSECA, Rafael. Retos y avances hacia la medicina de precisión en el mieloma múltiple. Medicina (B. Aires) [online]. 2017, vol.77, n.3, pp.222-226. ISSN 0025-7680.

In the last few years, next-generation sequencing studies have provided insights into the mutational landscape of multiple myeloma. The identification of actionable mutations might give a precious opportunity for exploring new targeted therapies. Thus, the implementation of promising precision medicine strategies seems to be closer than ever. Throughout this review we describe the main challenges that should to be dealt with in this new era, in order to achieve the main goal of precision medicine, namely matching patients with their right drug. In addition, we provide a review of the most significant preclinical and clinical studies supporting the implementation of precision medicine nowadays. Finally, we highlight the need of clinical trials to evaluate the security and efficacy of these targeted therapies, as well as to validate predictive biomarkers that may allow an appropriate best-candidate selection and improvement of myeloma patients' survival and quality of life.

Palabras clave : Personalized medicine; Multiple myeloma; Driver mutation; Targeted therapy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons